Cancer chemotherapy and dentistry.
D000477:Alkylating Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D002277:Carcinoma / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009062:Mouth Neoplasms / Q000188:drug therapy*; D011344:Procarbazine / Q000009:adverse effects; D012509:Sarcoma / Q000188:drug therapy; D014748:Vinca Alkaloids / Q000009:adverse effects
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D014748:Vinca Alkaloids; D011344:Procarbazine; D001215:Asparaginase